Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France.
Kabeshova, Anastasiia; Ben Hariz, Soumaia; Tsakeu, Elyonore; Benamouzig, Robert; Launois, Robert.
Affiliation
  • Kabeshova A; Network for Evaluation in Health Economics: REES France, Paris, France.
  • Ben Hariz S; Network for Evaluation in Health Economics: REES France, Paris, France.
  • Tsakeu E; Network for Evaluation in Health Economics: REES France, Paris, France.
  • Benamouzig R; Gastroenterology Department, Avicenne Hospital, Bobigny, France.
  • Launois R; Network for Evaluation in Health Economics: REES France, 28 rue d'Assas, 75006 Paris, France.
Therap Adv Gastroenterol ; 9(4): 473-82, 2016 Jul.
Article in En | MEDLINE | ID: mdl-27366216
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Health_economic_evaluation / Health_technology_assessment Aspects: Patient_preference Language: En Journal: Therap Adv Gastroenterol Year: 2016 Document type: Article Affiliation country: France Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Health_economic_evaluation / Health_technology_assessment Aspects: Patient_preference Language: En Journal: Therap Adv Gastroenterol Year: 2016 Document type: Article Affiliation country: France Country of publication: United kingdom